Brendan P. Eckelman - Chief Scientific Officer at Inhibrx Biosciences, Inc.

Insider Transactions and Holdings

Identity
Entity type
Individual
Role
Chief Scientific Officer
Issuer context
Issuer symbol
INBX on Nasdaq
SEC evidence
Source filings
Open source filing history

There are no Buy or Sell transactions made by Brendan P. Eckelman since 31 May 2025

Holdings reported by Brendan P. Eckelman for Inhibrx Biosciences, Inc.

Form 4 holding Chief Scientific Officer

Inhibrx Biosciences, Inc.

Security class
Common Stock
Shares / value
433,888
Estimated value
$5,610,172
Report date
29 May 2024
Price
$12.93
Ownership
By the Eckelman Living Trust Dated February 5, 2014
Form 4 holding Chief Scientific Officer

Inhibrx Biosciences, Inc.

Security class
Common Stock
Shares / value
40,000
Estimated value
$517,200
Report date
29 May 2024
Price
$12.93
Ownership
By trust
Form 4 holding Chief Scientific Officer

Inhibrx Biosciences, Inc.

Security class
Stock Option (right to buy)
Shares / value
175,000
Estimated value
Report date
30 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transactions reported by Brendan P. Eckelman for Inhibrx Biosciences, Inc.

Sym Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .